China Wind Power Group Co., Ltd., referred to as China Wind Power Group for short, and China Wind Power (English: China WindPower Group Limited, HKEx: 0 182) were renamed from Hong Kong Pharmaceutical Group Co., Ltd. on August 15, 2007. At present, it is mainly engaged in power plant investment, wind power design consulting and development services, power engineering construction services, wind farm operation and maintenance services, wind turbine tower manufacturing and other businesses. Liu Shunxing, Chairman and President of the Bank, and Chunshun Ko, Vice Chairman.
At the end of September, 2005, Chunshun Ko's family and related persons acquired the equity of Hong Kong Pharmaceutical, terminated the original pharmaceutical business [1] and switched to energy development. 20 1 1, they sold 49% equity of Fuxin Taihe to Liaoning Energy, a state-owned enterprise.